An Open Label Single Arm Clinical Trial of Amapachaka Vati in the Management of Amajirna
Journal of Ayurveda and Integrated Medical Sciences · 14.03.2026 · 11 (2) · 23-31
DOI: 10.21760/jaims.11.2.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ayurveda and Integrated Medical Sciences, online erschienen am 14.03.2026. Verfasst von Deepika Rathod und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Ayurvedic classics emphasize the pivotal role of Mandagni (Digestive impairment) as the root cause of many diseases, including Ajirna (Dyspepsia). Ajirna is classified into various types, Amajirna (Indigestion due to Ama) is one among them. Amajirna dominated by Kapha Dosha, presents with symptoms such as Shophakshigandayo (Swelling of periorbital region and cheeks), Sadhyobhukta Evodgara (Eructation of previous food), Praseka (Salivation), Utklesha (Nausea) and Gaurava (Heaviness in the body). If untreated, it may lead to severe conditions like Alasaka (Intestinal atony) and Vishuchika (Gastroenteritis with piercing pain). Classical Ayurvedic treatments emphasize Amapachana and Agnideepana. Amapachaka Vati is a well-known herbo-mineral formulation indicated in Agnimandhya and Ajirna. Present study was conducted to evaluate the efficacy of Amapachaka Vati in the management of Amajirna. Materials and Methods: The study was an open-label, single-arm clinical trial conducted on patients diagnosed with Amajirna. Participants were administered Amapachaka Vati, and their symptoms were assessed using predefined criteria. Other parameters such as Abhyavaharana Shakti, Jarana Shakti, and Mala Pariksha for Samata were evaluated before and after the treatment.
Results
The clinical trial showed highly significant improvement in symptoms such as Sadhyobhukta Evodgara, Praseka and Gaurava. Significant results were observed in Shophakshigandyo and Utklesha.
Conclusion
Amapachaka Vati demonstrated a significant therapeutic effect on Amajirna symptoms, with improving Abhyavaharana Shakti, Jarana Shakti, and Mala Pariksha for Samata. Further studies with larger sample sizes and longer durations are recommended to validate these findings and assess long-term efficacy.
Zitieren
APA
Rathod, D., Vyas, K., & Patel, J. (2026). An Open Label Single Arm Clinical Trial of Amapachaka Vati in the Management of Amajirna. Journal of Ayurveda and Integrated Medical Sciences, 11(2), 23-31. https://doi.org/10.21760/jaims.11.2.4
Vancouver
Rathod D, Vyas K, Patel J. An Open Label Single Arm Clinical Trial of Amapachaka Vati in the Management of Amajirna. Journal of Ayurveda and Integrated Medical Sciences. 2026;11(2):23-31. doi:10.21760/jaims.11.2.4
BibTeX
@article{Rathod2026,
author = {Rathod, Deepika and Vyas, Kruti and Patel, Jigisha},
title = {An Open Label Single Arm Clinical Trial of Amapachaka Vati in the Management of Amajirna},
journal = {Journal of Ayurveda and Integrated Medical Sciences},
year = {2026},
volume = {11},
number = {2},
pages = {23--31},
doi = {10.21760/jaims.11.2.4}
}
EUVIMED